India Glycols Limited (IGL) successfully conducted its Extraordinary General Meeting (EGM) on November 12, 2025, securing shareholder approval for a significant corporate action. The meeting, held through video conferencing, saw strong participation and resulted in the passage of a special resolution for the issuance of equity shares on a preferential basis.

Key Highlights of the EGM

• Meeting Details: The EGM was held on Wednesday, November 12, 2025, at 11:00 A.M. (IST) via video conference.
• Attendance: A total of 41 members participated in the meeting.
• Chairman: The meeting was chaired by Shri U.S. Bhartia, Chairman of India Glycols Limited.
• Voting Period: Remote e-voting was available from November 8-11, 2025, with additional e-voting facility provided during the EGM.

Voting Results

The special resolution to approve the issuance of equity shares on a preferential basis received overwhelming support from shareholders:

Procedural Highlights

1. Scrutinizer: Shri Ashish Saxena (C.P. No. 7096) of M/s Ashish Saxena & Co., Company Secretaries, was appointed as the scrutinizer for the voting process.
2. Transparency: The company provided remote e-voting facilities and e-voting during the EGM to ensure maximum shareholder participation.
3. Shareholder Engagement: Members were given opportunities to express views, ask questions, and seek clarifications on the proposed resolution.
4. Compliance: The EGM was conducted in compliance with the Securities and Exchange Board of India (SEBI) Listing Regulations and the Companies Act, 2013.

Management Commentary

Shri U.S. Bhartia, Chairman of India Glycols Limited, addressed the shareholders during the EGM and shared information about the rationale behind the preferential issue of shares. The management expressed gratitude for the shareholders' continued support and confidence in the company's strategic decisions.

Conclusion

The successful passage of the special resolution for the preferential issue of equity shares marks a significant step for India Glycols Limited. This corporate action may potentially strengthen the company's capital structure and support its future growth initiatives. Shareholders and market observers will likely keep a close watch on how the company utilizes this mandate in the coming months.

India Glycols Limited continues to demonstrate its commitment to transparent corporate governance and shareholder engagement through its well-organized EGM process and comprehensive disclosure of voting results.

India Glycols Limited (IGL) has announced a significant move to raise capital through a preferential share issue, as approved by its Board of Directors. The company plans to issue up to 51,03,765 equity shares at Rs 915 per share, aiming to raise a total of Rs 466.99 crore. This strategic decision, which requires shareholder approval, involves both promoter and non-promoter categories and is set to strengthen the company's financial position.

Key Details of the Preferential Issue

Allocation Breakdown

The preferential issue includes a diverse range of investors, with the promoter group and various non-promoter entities participating. Here's a breakdown of the major allottees:

Regulatory Compliance and Next Steps

The preferential issue has been structured in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. India Glycols has scheduled an Extra-Ordinary General Meeting (EGM) for November 12, 2025, to seek shareholder approval for this capital raise. The meeting will be conducted through video conferencing, adhering to current corporate governance practices.

Implications for Investors

This move by India Glycols Limited signifies a proactive approach to strengthening its capital base. The inclusion of both promoter and non-promoter investors in the preferential issue suggests a balanced approach to fundraising, potentially aligning various stakeholder interests.

Investors should note that while this capital infusion may provide the company with additional resources for growth or debt reduction, it will also lead to equity dilution. The impact on existing shareholders' holdings and the specific use of funds will be crucial factors to watch in the coming months.

As the company moves forward with this significant corporate action, market participants will likely keep a close eye on how India Glycols utilizes this fresh capital to drive its business strategies and enhance shareholder value.